Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Respiratory Research
Published in: Respiratory Research 1/2014

Open Access 01-12-2014 | Research

Therapeutic effects of amniotic fluid-derived mesenchymal stromal cells on lung injury in rats with emphysema

Authors: Yaqing Li, Chao Gu, Wulin Xu, Jianping Yan, Yingjie Xia, Yingyu Ma, Chun Chen, Xujun He, Houquan Tao

Published in: Respiratory Research | Issue 1/2014

Login to get access

Abstract

Background

In chronic obstructive pulmonary disease (COPD), two major pathological changes that occur are the loss of alveolar structure and airspace enlargement. To treat COPD, it is crucial to repair damaged lung tissue and regenerate the lost alveoli. Type II alveolar epithelial cells (AECII) play a vital role in maintaining lung tissue repair, and amniotic fluid-derived mesenchymal stromal cells (AFMSCs) possess the characteristics of regular mesenchymal stromal cells. However, it remains untested whether transplantation of rat AFMSCs (rAFMSCs) might alleviate lung injury caused by emphysema by increasing the expression of surfactant protein (SP)A and SPC and inhibiting AECII apoptosis.

Methods

We analyzed the phenotypic characteristics, differentiation potential, and karyotype of rAFMSCs, which were isolated from pregnant Sprague–Dawley rats. Moreover, we examined the lung morphology and the expression levels of SPA and SPC in rats with emphysema after cigarette-smoke exposure and intratracheal lipopolysaccharide instillation and rAFMSC transplantation. The ability of rAFMSCs to differentiate was measured, and the apoptosis of AECII was evaluated.

Results

In rAFMSCs, the surface antigens CD29, CD44, CD73, CD90, CD105, and CD166 were expressed, but CD14, CD19, CD34, and CD45 were not detected; rAFMSCs also strongly expressed the mRNA of octamer-binding transcription factor 4, and the cells could be induced to differentiate into adipocytes and osteocytes. Furthermore, rAFMSC treatment up-regulated the levels of SPA, SPC, and thyroid transcription factor 1 and inhibited AECII apoptosis, and rAFMSCs appeared to be capable of differentiating into AECII-like cells. Lung injury caused by emphysema was alleviated after rAFMSC treatment.

Conclusions

rAFMSCs might differentiate into AECII-like cells or induce local regeneration of the lung alveolar epithelium in vivo after transplantation and thus could be used in COPD treatment and lung regenerative therapy.
Appendix
Available only for authorised users
Literature
1.
Burgel PR: Pathogenesis of chronic obstructive pulmonary disease. Presse Med. 2009, 38: 406-412. 10.1016/j.lpm.2008.12.003.PubMedCrossRef
2.
Mizutani N, Fuchikami J, Takahashi M, Nabe T, Yoshino S, Kohno S: Pulmonary emphysema induced by cigarette smoke solution and lipopolysaccharide in guinea pigs. Biol Pharm Bull. 2009, 32: 1559-1564. 10.1248/bpb.32.1559.PubMedCrossRef
3.
Siganaki M, Koutsopoulos AV, Neofytou E, Vlachaki E, Psarrou M, Soulitzis N, Pentilas N, Schiza S, Siafakas NM, Tzortzaki EG: Deregulation of apoptosis mediators' p53 and bcl2 in lung tissue of COPD patients. Respir Res. 2010, 11: 46-10.1186/1465-9921-11-46.PubMedPubMedCentralCrossRef
4.
Hoffman AM, Ingenito EP: Alveolar epithelial stem and progenitor cells, emerging evidence for their role in lung regeneration. Curr Med Chem. 2012, 19: 6003-6008. 10.2174/092986712804485872.PubMedCrossRef
5.
Whitsett JA, Wert SE, Weaver TE: Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. Annu Rev Med. 2010, 61: 105-119. 10.1146/annurev.med.60.041807.123500.PubMedPubMedCentralCrossRef
6.
Bonfield TL, Caplan AI: Adult mesenchymal stem cells, an innovative therapeutic for lung diseases. Discov Med. 2010, 9: 337-345.PubMed
7.
Moodley Y, Manuelpillai U, Weiss DJ: Cellular therapies for lung disease, a distant horizon. Respirology. 2011, 16: 223-237. 10.1111/j.1440-1843.2010.01914.x.PubMedCrossRef
8.
Sinclair K, Yerkovich ST, Chambers DC: Mesenchymal stem cells and the lung. Respirology. 2013, 18: 397-411. 10.1111/resp.12050.PubMedCrossRef
9.
Giangreco A, Arwert EN, Rosewell IR, Snyder J, Watt FM, Stripp BR: Stem cells are dispensable for lung homeostasis but restore airways after injury. Proc Natl Acad Sci U S A. 2009, 106: 9286-9291. 10.1073/pnas.0900668106.PubMedPubMedCentralCrossRef
10.
Conese M, Carbone A, Castellani S, Di Gioia S: Paracrine effects and heterogeneity of marrow-derived stem/progenitor cells, relevance for the treatment of respiratory diseases. Cells Tissues Organs. 2013, 197: 445-473. 10.1159/000348831.PubMedCrossRef
11.
Gaur M, Ritner C, Sievers R, Pedersen A, Prasad M, Bernstein HS, Yeghiazarians Y: Timed inhibition of p38MAPK directs accelerated differentiation of human embryonic stem cells into cardiomyocytes. Cytotherapy. 2010, 12: 807-817. 10.3109/14653249.2010.491821.PubMedPubMedCentralCrossRef
12.
Muguruma K, Sasai Y: In vitro recapitulation of neural development using embryonic stem cells, from neurogenesis to histogenesis. Dev Growth Differ. 2012, 54: 349-357. 10.1111/j.1440-169X.2012.01329.x.PubMedCrossRef
13.
Samadikuchaksaraei A, Bishop AE: Derivation and characterization of alveolar epithelial cells from murine embryonic stem cells in vitro. Methods Mol Biol. 2006, 330: 233-248.PubMed
14.
Wang D, Haviland DL, Burns AR, Zsigmond E, Wetsel RA: A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A. 2007, 104: 4449-4454. 10.1073/pnas.0700052104.PubMedPubMedCentralCrossRef
15.
Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA: Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol. 2007, 179: 1855-1863. 10.4049/jimmunol.179.3.1855.PubMedCrossRef
16.
van Haaften T, Byrne R, Bonnet S, Rochefort GY, Akabutu J, Bouchentouf M, Rey-Parra GJ, Galipeau J, Haromy A, Eaton F, Chen M, Hashimoto K, Abley D, Korbutt G, Archer SL, Thébaud B: Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respir Crit Care Med. 2009, 180: 1131-1142. 10.1164/rccm.200902-0179OC.PubMedPubMedCentralCrossRef
17.
Loi R, Beckett T, Goncz KK, Suratt BT, Weiss DJ: Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells. Am J Respir Crit Care Med. 2006, 173: 171-179. 10.1164/rccm.200502-309OC.PubMedPubMedCentralCrossRef
18.
Sueblinvong V, Loi R, Eisenhauer PL, Bernstein IM, Suratt BT, Spees JL, Weiss DJ: Derivation of lung epithelium from human cord blood-derived mesenchymal stem cells. Am J Respir Crit Care Med. 2008, 177: 701-711. 10.1164/rccm.200706-859OC.PubMedPubMedCentralCrossRef
19.
Moodley Y, Atienza D, Manuelpillai U, Samuel CS, Tchongue J, Ilancheran S, Boyd R, Trounson A: Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol. 2009, 175: 303-313. 10.2353/ajpath.2009.080629.PubMedPubMedCentralCrossRef
20.
Zhen G, Xue Z, Zhao J, Gu N, Tang Z, Xu Y, Zhang Z: Mesenchymal stem cell transplantation increases expression of vascular endothelial growth factor in papain-induced emphysematous lungs and inhibits apoptosis of lung cells. Cytotherapy. 2010, 12: 605-614. 10.3109/14653241003745888.PubMedCrossRef
21.
Huh JW, Kim SY, Lee JH, Lee JS, Van Ta Q, Kim M, Oh YM, Lee YS, Lee SD: Bone marrow cells repair cigarette smoke-induced emphysema in rats. Am J Physiol Lung Cell Mol Physiol. 2011, 301: L255-L266. 10.1152/ajplung.00253.2010.PubMedCrossRef
22.
Bonfield TL, Koloze M, Lennon DP, Zuchowski B, Yang SE, Caplan AI: Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. Am J Physiol Lung Cell Mol Physiol. 2010, 299: L760-L770. 10.1152/ajplung.00182.2009.PubMedPubMedCentralCrossRef
23.
Goodwin M, Sueblinvong V, Eisenhauer P, Ziats NP, LeClair L, Poynter ME, Steele C, Rincon M, Weiss DJ: Bone marrow-derived mesenchymal stromal cells inhibit Th2-mediated allergic airways inflammation in mice. Stem Cells. 2011, 29: 1137-1148. 10.1002/stem.656.PubMedPubMedCentralCrossRef
24.
Lee SH, Jang AS, Kim YE, Cha JY, Kim TH, Jung S, Park SK, Lee YK, Won JH, Kim YH, Park CS: Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury/fibrosis. Respir Res. 2010, 11: 16-10.1186/1465-9921-11-16.PubMedPubMedCentralCrossRef
25.
Kim ES, Chang YS, Choi SJ, Kim JK, Yoo HS, Ahn SY, Sung DK, Kim SY, Park YR, Park WS: Intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells attenuates Escherichia coli-induced acute lung injury in mice. Respir Res. 2011, 12: 108-10.1186/1465-9921-12-108.PubMedPubMedCentralCrossRef
26.
Weiss DJ, Casaburi R, Flannery R, LeRoux-Williams M, Tashkin DP: A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. Chest. 2013, 143: 1590-1598. 10.1378/chest.12-2094.PubMedCrossRef
27.
De Coppi P, Bartsch G, Siddiqui MM, Xu T, Santos CC, Perin L, Mostoslavsky G, Serre AC, Snyder EY, Yoo JJ, Furth ME, Soker S, Atala A: Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 2007, 25: 100-106. 10.1038/nbt1274.PubMedCrossRef
28.
Sun H, Feng K, Hu J, Soker S, Atala A, Ma PX: Osteogenic differentiation of human amniotic fluid-derived stem cells induced by bone morphogenetic protein-7 and enhanced by nanofibrous scaffolds. Biomaterials. 2010, 31: 1133-1139. 10.1016/j.biomaterials.2009.10.030.PubMedPubMedCentralCrossRef
29.
Joo S, Ko IK, Atala A, Yoo JJ, Lee SJ: Amniotic fluid-derived stem cells in regenerative medicine research. Arch Pharm Res. 2012, 35: 271-280. 10.1007/s12272-012-0207-7.PubMedCrossRef
30.
Hartmann K, Raabe O, Wenisch S, Arnhold S: Amniotic fluid derived stem cells give rise to neuron-like cells without a further differentiation potential into retina-like cells. Am J Stem Cells. 2013, 2: 108-118.PubMedPubMedCentral
31.
Sessarego N, Parodi A, Podestà M, Benvenuto F, Mogni M, Raviolo V, Lituania M, Kunkl A, Ferlazzo G, Bricarelli FD, Uccelli A, Frassoni F: Multipotent mesenchymal stromal cells from amniotic fluid, solid perspectives for clinical application. Haematologica. 2008, 93: 339-346. 10.3324/haematol.11869.PubMedCrossRef
32.
Cananzi M, Atala A, De Coppi P: Stem cells derived from amniotic fluid, new potentials in regenerative medicine. Reprod Biomed Online. 2009, 18: 17-27. 10.1016/S1472-6483(10)60111-3.PubMedCrossRef
33.
Carraro G, Perin L, Sedrakyan S, Giuliani S, Tiozzo C, Lee J, Turcatel G, De Langhe SP, Driscoll B, Bellusci S, Minoo P, Atala A, De Filippo RE, Warburton D: Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells. 2008, 26: 2902-2911. 10.1634/stemcells.2008-0090.PubMedPubMedCentralCrossRef
34.
Roubelakis MG, Trohatou O, Anagnou NP: Amniotic fluid and amniotic membrane stem cells, marker discovery. Stem Cells Int. 2012, 2012: 107836-10.1155/2012/107836.PubMedPubMedCentralCrossRef
35.
Li Y, Xu W, Yan J, Xia Y, Gu C, Ma Y, Tao H: Differentiation of human amniotic fluid-derived mesenchymal stem cells into type II alveolar epithelial cells in vitro. Int J Mol Med. 2014, 33: 1507-1513.PubMed
36.
Pan HC, Cheng FC, Chen CJ, Lai SZ, Lee CW, Yang DY, Chang MH, Ho SP: Post-injury regeneration in rat sciatic nerve facilitated by neurotrophic factors secreted by amniotic fluid mesenchymal stem cells. J Clin Neurosci. 2007, 14: 1089-1098. 10.1016/j.jocn.2006.08.008.PubMedCrossRef
37.
Zheng YB, Zhang XH, Huang ZL, Lin CS, Lai J, Gu YR, Lin BL, Xie DY, Xie SB, Peng L, Gao ZL: Amniotic-fluid-derived mesenchymal stem cells overexpressing interleukin-1 receptor antagonist improve fulminant hepatic failure. PLoS One. 2012, 7: e41392-10.1371/journal.pone.0041392.PubMedPubMedCentralCrossRef
38.
Colosimo A, Russo V, Mauro A, Curini V, Marchisio M, Bernabò N, Alfonsi M, Mattioli M, Barboni B: Prolonged in vitro expansion partially affects phenotypic features and osteogenic potential of ovine amniotic fluid-derived mesenchymal stromal cells. Cytotherapy. 2013, 15: 930-950. 10.1016/j.jcyt.2013.03.014.PubMedCrossRef
39.
Zheng H, Liu Y, Huang T, Fang Z, Li G, He S: Development and characterization of a rat model of chronic obstructive pulmonary disease (COPD) induced by sidestream cigarette smoke. Toxicol Lett. 2009, 189: 225-234. 10.1016/j.toxlet.2009.06.850.PubMedCrossRef
40.
Jiang H, Zhu Y, Xu H, Sun Y, Li Q: Activation of hypoxia-inducible factor-1alpha via nuclear factor-kappa B in rats with chronic obstructive pulmonary disease. Acta Biochim Biophys Sin (Shanghai). 2010, 42: 483-488. 10.1093/abbs/gmq041.CrossRef
41.
Agarwal AR, Yin F, Cadenas E: Short-term cigarette smoke exposure leads to metabolic alterations in lung alveolar cells. Am J Respir Cell Mol Biol. 2014, 51: 284-293.PubMed
42.
Li YQ, Yan JP, Xu WL, Wang H, Xia YJ, Wang HJ, Zhu YY, Huang XJ: ADAM17 mediates MMP9 expression in lung epithelial cell. PLoS One. 2013, 8: e51701-10.1371/journal.pone.0051701.PubMedPubMedCentralCrossRef
43.
Farkas L, Farkas D, Warburton D, Gauldie J, Shi W, Stampfli MR, Voelkel NF, Kolb M: Cigarette smoke exposure aggravates air space enlargement and alveolar cell apoptosis in Smad3 knockout mice. Am J Physiol Lung Cell Mol Physiol. 2011, 301: L391-L401. 10.1152/ajplung.00369.2010.PubMedCrossRef
44.
Macnee W: Pathogenesis of chronic obstructive pulmonary disease. Clin Chest Med. 2007, 28: 479-513. 10.1016/j.ccm.2007.06.008.PubMedCrossRef
45.
Martin TR: Recognition of bacterial endotoxin in the lungs. Am J Respir Cell Mol Biol. 2000, 23: 128-132. 10.1165/ajrcmb.23.2.f189.PubMedCrossRef
46.
Sun D, Bu L, Liu C, Yin Z, Zhou X, Li X, Xiao A: Therapeutic effects of human amniotic fluid-derived stem cells on renal interstitial fibrosis in a murine model of unilateral ureteral obstruction. PLoS One. 2013, 8: e65042-10.1371/journal.pone.0065042.PubMedPubMedCentralCrossRef
47.
Donovan PJ: High Oct-ane fuel powers the stem cell. Nat Genet. 2001, 29: 246-247. 10.1038/ng1101-246.PubMedCrossRef
48.
Pesce M, Gross MK, Schöler HR: In line with our ancestors, Oct-4 and the mammalian germ. Bioessays. 1998, 20: 722-732. 10.1002/(SICI)1521-1878(199809)20:9<722::AID-BIES5>3.0.CO;2-I.PubMedCrossRef
49.
Prusa AR, Marton E, Rosner M, Bernaschek G, Hengstschl ger M: Oct-4-expressing cells in human amniotic fluid, a new source for stem cell research?. Hum Reprod. 2003, 18: 1489-1493. 10.1093/humrep/deg279.PubMedCrossRef
50.
Jomura S, Uy M, Mitchell K, Dallasen R, Bode CJ, Xu Y: Potential treatment of cerebral global ischemia with Oct-4+ umbilical cord matrix cells. Stem Cells. 2007, 25: 98-106. 10.1634/stemcells.2006-0055.PubMedCrossRef
51.
Tondeur S, Assou S, Nadal L, Hamamah S, De Vos J: Biology and potential of human embryonic stem cells. Ann Biol Clin (Paris). 2008, 66: 241-247.
52.
Goldmann T, K hler D, Schultz H, Abdullah M, Lang DS, Stellmacher F, Vollmer E: On the significance of Surfactant Protein-A within the human lungs. Diagn Pathol. 2009, 4: 8-10.1186/1746-1596-4-8.PubMedPubMedCentralCrossRef
53.
Fujino N, Kubo H, Suzuki T, Ota C, Hegab AE, He M, Suzuki S, Suzuki T, Yamada M, Kondo T, Kato H, Yamaya M: Isolation of alveolar epithelial type II progenitor cells from adult human lungs. Lab Invest. 2011, 91: 363-378. 10.1038/labinvest.2010.187.PubMedPubMedCentralCrossRef
54.
Buckley S, Shi W, Carraro G, Sedrakyan S, Da Sacco S, Driscoll BA, Perin L, De Filippo RE, Warburton D: The milieu of damaged alveolar epithelial type 2 cells stimulates alveolar wound repair by endogenous and exogenous progenitors. Am J Respir Cell Mol Biol. 2011, 45: 1212-1221. 10.1165/rcmb.2010-0325OC.PubMedPubMedCentralCrossRef
Metadata
Title
Therapeutic effects of amniotic fluid-derived mesenchymal stromal cells on lung injury in rats with emphysema
Authors
Yaqing Li
Chao Gu
Wulin Xu
Jianping Yan
Yingjie Xia
Yingyu Ma
Chun Chen
Xujun He
Houquan Tao
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2014
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-014-0120-3

Other articles of this Issue 1/2014

Respiratory Research 1/2014 Go to the issue

Commentary

Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis

Research

Increased of exhaled breath condensate neutrophil chemotaxis in acute exacerbation of COPD

Research

17β-estradiol suppresses lipopolysaccharide-induced acute lung injury through PI3K/Akt/SGK1 mediated up-regulation of epithelial sodium channel (ENaC) in vivo and in vitro

Research

Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, randomized, double-blind, placebo-controlled study

Review

Inflammatory cytokines in pulmonary hypertension

Research

Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits